Seroprevalence of Chlamydia trachomatis IgA, IgM and IgG Antibodies and Associated Risk Factors among Sexually Active Individuals at Saint Vincent de Paul Hospital in Dschang, West Cameroon
International STD Research & Reviews,
Background: Chlamydia trachomatis is the most common cause of sexually transmitted infections worldwide. Infections caused by this pathogen are usually symptomatic in men and asymptomatic in about 2/3 of women resulting in a variety of clinical complications.
Aim: To determine the seroprevalence of immunological markers and the risk factors associated with the seropositivity to C. trachomatis infection in sexually active individuals visiting the Saint Vincent de Paul Hospital in Dschang, West region Cameroon
Study Design: This was an analytical cross-sectional study conducted between July and September 2020 at Saint Vincent de Paul Hospital in Dschang, Cameroon.
Methods: A total of 154 participants were recruited during the data collection period. An indirect ELISA method was used to analyse participant’s serum samples. Risk factors were assessed through univariate and multivariate logistic regression using SPSS 25.
Results: The seroprevalence of C. trachomatis infection was 38.3% (95%CI: 30.6 - 46.0). Only 39.6% (95%CI: 31.6 - 47.3) of the study population had never been in contact with the bacterium. The reinfection rate among participants was 8.4% (95%CI: 4.0 - 12.8). Results revealed that being Male is a protective factor against the infection [aOR: 0.12; 95% CI: 0.03 - 0.56; P ꞊ .007]. The non-use of condom [aOR: 21.58; 95% CI: 3.53 – 132.06; P ꞊ .001] and having encountered three or more sexual partners [aOR: 9.90; 95%CI: 1.07 – 91.60; P ꞊ .043] were the significant predictors of Chlamydia seropositivity.
Conclusion: The implementation of proactive strategies to curb down the spread of the infection is necessary in this locality. This can be done by providing NAATs to as many health facilities as possible, educating the population and standardizing treatment protocols.
- Chlamydia trachomatis
- risk factors
How to Cite
De Barbeyrac B, Bébéar C. Chlamydial pathogenesis: Diagnostic and therapeutic consequences. Arch Pediatr 2005;12:S26–31.
De Barbeyrac B, Obeniche F, Ratsima E, Labrouche S, Moraté C, Renaudin H, et al. Limites et perspectives du diagnostic sérologique à l’ère de l’amplification génique in vitro: Infections génitales à Chlamydia trachomatis et infections respiratoires à Chlamydia pneumoniae et Mycoplasma pneumoniae. Ann Biol Clin (Paris) 2006;64:409–19.
Kristen M Kreisel, Ian H Spicknall, Julia W Gargano, Felicia M T Lewis, Rayleen M Lewis, Lauri E Markowitz et al. Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018. Sex Transm Dis. 2021;48(4):208-214.
O’Farrell Nigel, Morison Linda, Moodley Prashini, Pillay Keshree, Vanmali Trusha, Quigley Maria et al. Genital Ulcers and Concomitant Complaints in Men Attending a Sexually Transmitted Infections Clinic: Implications for Sexually Transmitted Infections Management. Sexually Transmitted Diseases. 2008;35(6):545-549.
White John A. Manifestations and management of lymphogranuloma venereum. Current Opinion in Infectious Diseases. 2009;22(1):57-66.
CDC. Sexually Transmitted Disease Surveillance; 2019.
Frommell G, Rothenberg R, Wang S. KennethMcIntosh, B.A.CynthiaWintersgill, B.S. Jane Allaman et al. Chlamydial infection of mothers and their infants. The Journal of Pediatrics. 1979;95(1):28-32.
Ingrid G, Rours JG, Duijts L, Moll HA, Arends LR, Ronald De Groot, et al. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: A population-based prospective cohort study. Springer n.d.
Howell Mr, Quinn Tc, Brathwaite W, Gaydos Ca. Screening_Women_forChlamydia_trachomatisin_Family. The Cost-Effectiveness of DNA Amplification Assays. Sex Transm Dis. 1998;25:108–17.
Washington AE, Katz P. Cost of and Payment Source for Pelvic Inflammatory Disease: Trends and Projections, 1983 Through 2000. J Am Med Assoc. 1991;266:2565–9.
Tsakeu E, Kamgaing J, Lekefack F, Emile T. Contribution of the ELISA and PCR tests in thediagnosis of Chlamydia trachomatis infectionin fertile and infertile women in resource-limitedsettings-a case-control stud. Eur Gynecol Obstet. 2020;2:249–54.
Numazaki K, Chiba S, Umetsu M. Detection of IgM antibodies to Chlamydia trachomatis, Chlamydia pneumoniae, and Chlamydia psittaci from Japanese infants and children with pneumonia. In Vivo (Brooklyn). 1992;6:601–4.
Joyee AG, Thyagarajan SP, Vikram Reddy E, et al. Diagnostic utility of serologic markers for genital chlamydial infection in STD patients in Chennai, India. The Journal of the Association of Physicians of India. 2007;55:777-780.
Woodhall SC, Gorwitz RJ, Migchelsen SJ, Gottlieb SL, Horner PJ, Geisler WM, et al. Personal View Advancing the public health applications of Chlamydia trachomatis serology. Lancet Infect Dis. 2018;3099:1–9.
Theophile NN, Jules Clement AN, Engowei C, C TN, C NN. Current Management and Government Policies on Sexually Transmitted Mycoplasma and Chlamydia infections in the context of infertility: The case of Cameroon. African J Integr Heal. 2016;6:54–6.
Tadongfack TD, Nitcheu ILS, Keubo FRN, Mutarambirwa HD, Tedjieu RH, Tatang CT, et al. Epidemiology, prevalence and antimicrobial susceptibility of sexually transmitted mycoplasma hominis and ureaplasma urealyticum infections in dschang, west cameroon. Microbiology Research Journal International. 2020;30(11):19-29.
Santé Publique France. Épidémiologie Des Infections Sexuellement Transmissibles. 2019.
Lamontagne DS, Fenton KA, Randall S, Anderson S, Carter P, Lamontagne S. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex Transm Infect. 2004;80:335–41.
Ngandjio A, Clerc M, Fonkoua MC, Thonnon J, Njock F, Pouillot R, et al. Screening of volunteer students in Yaounde (Cameroon, Central Africa) for Chlamydia trachomatis infection and genotyping of isolated C. trachomatis strains. J Clin Microbiol 2003; 41:4404–7.
Essome MCN, Nsawir BJ, Nana RD, Molu P, Mohamadou M. Sero-epidemiological study of three sexually transmitted infections: Chlamydia Trachomatis, Hepatitis B, Syphilis. A case study conducted at the Nkoldongo District Hospital in Yaoundé. Pan Afr Med J 2016;25.
Nguefack CT, Mefo JN, Tchuinte S, Demafo L. Contribution of the ELISA and PCR tests in the diagnosis of Chlamydia trachomatis infection in fertile and infertile women in resource-limited settings : a case-control study. Eur Gynecol Obstet. 2020;2:249–54.
Araújo RSC, Guimarães EMB, Alves MFC, Sakurai E, Domingos LT, Fioravante FCR, et al. Prevalence and risk factors for Chlamydia trachomatis infection in adolescent females and young women in central Brazil. Eur J Clin Microbiol Infect Dis 2006;25:397–400.
DOI : 10.1007/s10096-006-0142-y
Bas S, Muzzin P, Ninet B, Bornand JE, Scieux C. Chlamydial Serology : Comparative Diagnostic Value of Immunoblotting, Micro immunofluorescence Test and Immunoassays Using Different Recombinant Proteins as Antigens 2001; 39:1368–77.
Muvunyi CM, Dhont N, Verhelst R, Temmerman M, Claeys G, Padalko E. Chlamydia trachomatis infection in fertile and subfertile women in Rwanda: Prevalence and diagnostic significance of IgG and IgA antibodies testing. Hum Reprod. 2011;26:3319–26.
Páez-Canro C, Alzate JP, González LM, Rubio-Romero JA, Lethaby A, Gaitán HG. Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women. Cochrane Database Syst Rev 2019;2019.
WHO. Global Health Sector Strategy On Sexually Transmitted Infections 2016–2021; 2016.
Syred J, Engler B, Campbell L, Baraitser P, Sheringham J. Exploration of gender differences of Chlamydia trachomatis infection amongst young people reveals limitations of using sexual histories to assess risk in high-prevalence areas. Int J STD AIDS. 2014;25:564–70.
Abstract View: 231 times
PDF Download: 99 times